skip to Main Content

Scale-up production, expand US ‑Sales: JENETRIC GmbH pursues ambitious goals with the third funding round

  • 2016

The Ger­man bio­met­rics com­pany was able to inspire its investors to par­tic­i­pate in another invest­ment round and win a new Busi­ness Angel

After a very suc­cess­ful year, the Ger­man bio­met­rics com­pany looks ahead into a finan­cially secure future. JENETRIC’s investors con­firmed addi­tional fund­ing for a third invest­ment round. The com­pany was sup­ported by VENTRADA Cor­po­rate Finance GmbH in the plan­ning of the new invest­ment round.

A strat­egy con­se­quently focused on rev­enue and exten­sion of the prod­uct port­fo­lio has con­vinced us to once more invest into the pow­er­ful JENETRIC team”, said Karin Rabe, invest­ment man­ager at bm|t, the invest­ment com­pany of the Free State of Thuringia.

Fur­ther­more, the “High-Tech Grün­der­fonds (HTGF)“ wants to engage again. The JENETRIC man­age­ment is par­tic­u­larly pleased that apart from Prof. Dr. Franz Schmidt another Thuringian busi­ness angel teams up. “I am look­ing for­ward to actively sup­port the devel­op­ment of JENETRIC as new investor. I am con­vinced that the inno­v­a­tive prod­ucts will not only become glob­ally com­pat­i­ble but also gain a lead­ing mar­ket posi­tion”, said Dr. Uwe Trautmann.

Our investors’ trust inspires and moti­vates us fur­ther. With the addi­tional funds we mainly want to expand our pro­duc­tion capac­ity and hit the ground run­ning in the U.S. mar­ket”, said Roberto Wolfer, one of the founders and CEO of JENETRIC. To pro­vide their cus­tomers in the U.S. with the best pos­si­ble ser­vice, the com­pany plans to estab­lish a sub­sidiary there next year. “The U.S.A. are pio­neers and one of the most impor­tant mar­kets for bio­met­rics. For us the prox­im­ity to the crit­i­cal mul­ti­pli­ers of the indus­try is essen­tial. This is the only way we can ensure the require­ments for future bio­met­ric appli­ca­tions are cap­tured in time and hence imple­mented in our products.”

The com­pany already has two unique fin­ger­print scan­ners on the mar­ket: the LIVETOUCH® quat­tro with inte­grated user guid­ance and the very com­pact mod­ule LIVETOUCH quat­tro Com­pact for the inte­gra­tion into portable enrol­ment kits.

JENETRIC will expand its prod­uct range in the com­ing year. The future LIVETOUCH quat­tro Mobile will be the first prod­uct from the LIVETOUCH prod­uct fam­ily sup­port­ing the mobile enrol­ment of fingerprints.


JENETRIC GmbH was founded in 2014 in Jena, Ger­many — a loca­tion famous for cut­ting-edge opti­cal tech­nol­ogy — by engi­neers with long­time expe­ri­ence in fin­ger­print tech­nol­ogy and has spe­cial­ized on the devel­op­ment on bio­met­ric sys­tems. The mul­ti­dis­ci­pli­nary team includes hard­ware and soft­ware spe­cial­ists as well as pro­duc­tion and sales pro­fes­sion­als. The com­pany is financed by the resources of the team, two busi­ness angels and by the “Thuringian Grün­der­fond” as well as by the „High-Tech Grün­der­fonds“. The com­pany fol­lows in its prod­uct devel­op­ment a holis­tic approach clearly ori­ented towards cus­tomer require­ments — with the ambi­tious goal of improv­ing the liv­ing and work­ing con­di­tions through the use of bio­met­ric systems.

About High-Tech Gründerfonds

High-Tech Grün­der­fonds invests in young, high poten­tial high-tech start-ups. The seed financ­ing pro­vided is designed to enable start-ups to take an idea through pro­to­typ­ing and to mar­ket launch. Typ­i­cally, High-Tech Grün­der­fonds invests EUR 600,000 in the seed stage, with the poten­tial for up to a total of EUR 2 mil­lion per port­fo­lio com­pany in fol­low-on financ­ing. Investors in this public/private part­ner­ship include the Fed­eral Min­istry of Eco­nom­ics and Energy, the KfW Bank­ing Group, as well as strate­gic cor­po­rate investors includ­ing ALTANA, BASF, Bayer, B. Braun, Robert Bosch, CEWE, Daim­ler, Deutsche Post DHL, Deutsche Telekom, Evonik, Innogy, Lanxess, media + more ven­ture Beteili­gungs GmbH & Co. KG, METRO, Qia­gen, SAP, Ten­gel­mann and Carl Zeiss. High-Tech Grün­der­fonds has about EUR 576 mil­lion under man­age­ment in two funds (EUR 272 mil­lion HTGF I, EUR 304 mil­lion HTGF II).


About bm|t beteiligungsmanagement thüringen gmbh

The Erfurt-based bm|t beteili­gungs­man­age­ment thürin­gen gmbh – a sub­sidiary of the Thüringer Auf­baubank – is the man­age­ment com­pany for six invest­ment funds with a total vol­ume of 250 m €. bm|t invests in inno­v­a­tive com­pa­nies of all high-yield sec­tors and in all stages of a company’s life cycle, from start-up to IPO or MBO.

Back To Top
×Close search